Many previous studies have shown that ki67 is overexpressed in many malignant tumors, such as breast cancer, lung cancer, and colorectal cancer (CRC), and that it is related to the development, metastasis, and survival prognosis of tumors (20–22). This evidence concerns the gene MKI67 and colorectal carcinoma.